In this scoping review, we present and map the available clinical evidence of the prognostic and predictive value of K17 in human cancers, particularly those of viral origin, identify potential knowledge gaps, and discuss emerging concepts and clinical opportunities for K17 in the era of immuno-oncology. Here, KRT17 is linked to cancer.